Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: A meta-analysis

Urologia Internationalis

Volumn 88, Issue 1, 2012, Pages 88-94

  Li, Dawei ^a   Liu, Hainan ^a   Yan, Lei ^a   Tang, Yueqing ^a   Ren, Juchao ^a   Xu, Zhonghua ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Bladder cancer; hOGG1; Meta analysis; Polymorphism

Indexed keywords

ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DNA GLYCOSYLASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84856410348     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000331931     Document Type: Article

References (36)

1. Ploeg M, Aben KK, Kiemeney LA: The present and future burden of urinary bladder cancer in the world. World J Urol 2009;27:289-293.
2. Murta-Nascimento C, Schmitz-Dräger BJ, Zeegers MP, Steineck G, Kogevinas M, Real FX, Malats N: Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol 2007;25:285-295.
3. Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, Brennan P, Bartsch H, Wiangnon S, Popanda O: Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat 2008;111:279-288.
4. Janssen K, Schlink K, Götte W, Hippler B, Kaina B, Oesch F: DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutat Res 2001;486:207-216.
5. Rossner P, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK, Gaudet MM, Neugut AI, Santella RM: OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:811-815.
6. Loder N: Genetic variations can point the way to disease genes. Nature 1999;401:734.
7. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-1530.
8. Xing DY, Tan W, Song N, Lin DX: Ser326cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 2001;95:140-143.
9. Hill JW, Evans MK: A novel R229Q OGG1 polymorphism results in a thermolabile enzyme that sensitizes KG-1 leukemia cells to DNA damaging agents. Cancer Detect Prev 2007;31:237-243.
10. Nohmi T, Kim SR, Yamada M: Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes. Mutat Res 2005;591:60-73.
11. Weiss JM, Goode EL, Ladiges WC, Ulrich CM: Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127-141.
12. Gangwar R, Ahirwar D, Mandhani A, Mittal RD: Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the north Indian population? Mutat Res 2009;680:56-63.
13. Narter KF, Ergen A, Agaçhan B, Görmüs U, Timirci O, Isbir T: Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 2009;29:1389-1393.
14. Arizono K, Osada Y, Kuroda Y: DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 2008;38:186-191.
15. Figueroa JD, Malats N, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Rothman N, García-Closas M: Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007;121:233-242.
16. Karahalil B, Kocabas NA, Ozçelik T: DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 2006;26:4955-4958.
17. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR: Bladder cancer predisposition: a multigenic approach to DNArepair and cell-cycle-control genes. Am J Hum Genet 2006;78:464-479.
18. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ, Kang JW, Lee SC, Jun. Wee J, Kim WJ: Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology 2005;65:70-75.
19. Zintzaras E, Ioannidis JP: Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 2005;28:123-137.
20. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
21. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826.
22. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J: A method for meta-analysis of molecular association studies. Stat Med 2005;24:1291-1306.
23. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
24. Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X: High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007;16:84-91.
25. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-182.
26. Egger M, Smith GD, Phillips AN: Meta-analysis: principles and procedures. BMJ 1997;315:1533-1537.
27. Ding DP, Zhang Y, He XF: Lack of association between hOGG1 Ser326Cys polymorphism and breast cancer susceptibility in European population. Breast Cancer Res Treat 2011;129:1023-1026.
28. Gu D, Wang M, Zhang Z, Chen J: Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Breast Cancer Res Treat 2010;122:527-531.
29. Zhang Y, He BS, Pan YQ, Xu YQ, Wang SK: Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a metaanalysis. Int J Colorectal Dis 2011, Epub ahead of print.
30. Li H, Hao X, Zhang W, Wei Q, Chen K: The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:1739-1745.
31. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S: Excision of oxidatively damaged DNA bases by the human alpha-hOGG1 protein and the polymorphic alpha-hOGG1 (Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res 1999;27:4001-4007.
32. Tarng DC, Tsai TJ, Chen WT, Liu TY, Wei YH: Effect of human OGG1 1245C-> G gene polymorphism on 8-hydroxy-2′-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J Am Soc Nephrol 2001;12:2338-2347.
33. Yamane A, Kohno T, Ito K, Sunaga N, Aoki K, Yoshimura K, Murakami H, Nojima Y, Yokota J: Differential ability of polymorphic OGG1 proteins to suppress mutagenesis induced by 8-hydroxyguanine in human cell in vivo. Carcinogenesis 2004;25:1689-1694.
34. Lee AJ, Hodges NJ, Chipman JK: Interindividual variability in response to sodium dichromateinduced oxidative DNA damage: role of the Ser326Cys polymorphism in the DNA-repair protein of 8-oxo-7, 8-dihydro-2 ′-deoxyguanosine DNA glycosylase 1. Cancer Epidemiol Biomarkers Prev 2005;14:497-505.
35. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP: Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 2006;163:300-309.
36. Salanti G, Amountza G, Ntzani EE, Ioannidis JP: Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 2005;13:840-848.